| Unique ID issued by UMIN | UMIN000062645 |
|---|---|
| Receipt number | R000071706 |
| Scientific Title | Effects of pre-exercise protein ingestion on performance and executive function |
| Date of disclosure of the study information | 2026/08/21 |
| Last modified on | 2026/08/21 11:21:05 |
Effects of pre-exercise protein ingestion on performance and executive function
Effects of pre-exercise protein ingestion on performance and executive function
Effects of pre-exercise protein ingestion on performance and executive function
Effects of pre-exercise protein ingestion on performance and executive function
| Japan |
Healthy adults
| Adult |
Others
NO
This study aims to clarify the effects of pre-exercise protein ingestion on performance in resistance and endurance exercise, and on executive function after exercise.
Efficacy
Study 1: total number of repetitions across five sets of leg press performed to volitional failure at 70% of one-repetition maximum. Study 2: time to exhaustion during incremental cycling exercise.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
2
Treatment
| Food |
A single dose of whey protein (SAVAS Aqua Whey Protein 100, Meiji Co., Ltd.) equivalent to 0.4 g of protein per kilogram of body weight (approximately 0.56 g of powder per kilogram, up to a maximum of 56 g of powder per dose), dissolved in 400 mL of water, is ingested 60 minutes before exercise. The exercise task starts 60 minutes after ingestion.
Only 400 mL of water is ingested 60 minutes before exercise. The same exercise task as in the protein arm starts 60 minutes after ingestion. The two conditions are administered in a randomized crossover order, with an interval of at least one week between conditions.
| 18 | years-old | <= |
| 30 | years-old | >= |
Male and Female
Healthy adults affiliated with Niigata University of Health and Welfare. Aged 18 to 30 years. Both sexes are eligible. Not restricted from exercising by a physician. Provided written informed consent after receiving an explanation of the study.
Individuals in poor physical condition (fever of 38 or higher, marked palpitations, shortness of breath, severe fatigue, or cold sweat). Individuals diagnosed at a health checkup with hypertension (resting blood pressure of 180/110 mmHg or higher), heart disease, or an infectious disease. Individuals with a history of cardiovascular disease, an orthopedic or neurological disorder requiring exercise restriction, or a serious medical condition currently under treatment, or who have been advised by a physician to restrict exercise. Individuals with an allergy to milk, dairy products, or soy. Individuals with a history of kidney disease. Individuals who habitually take protein supplements. Individuals with color vision deficiency.
48
| 1st name | Genta |
| Middle name | |
| Last name | Ochi |
Niigata University of Health and Welfare
Faculty of Health Sciences, Department of Health and Sports
950-3198
1398 Shimami-cho, Kita-ku, Niigata-City
025-257-4595
ochi@nuhw.ac.jp
| 1st name | Genta |
| Middle name | |
| Last name | Ochi |
Niigata University of Health and Welfare
Faculty of Health Sciences, Department of Health and Sports
950-3198
1398 Shimami-cho, Kita-ku, Niigata-City
025-257-4595
ochi@nuhw.ac.jp
Niigata University of Health and Welfare
Niigata University of Health and Welfare
Other
Niigata University of Health and Welfare
1398 Shimami-cho, Kita-ku, Niigata-City
025-257-4455
rinri@nuhw.ac.jp
NO
| 2026 | Year | 08 | Month | 21 | Day |
Unpublished
Preinitiation
| 2026 | Year | 08 | Month | 21 | Day |
| 2026 | Year | 09 | Month | 01 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 08 | Month | 21 | Day |
| 2026 | Year | 08 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071706